Calton & Associates, Inc. Gilead Sciences, Inc. Transaction History

Calton & Associates, Inc.

$250 Million
Q3 2024

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Jan 13, 2022	SELL	$64.88 - $73.64 $256,795 - $291,467	-3,958 Closed	0 $0
Q3 2021 Nov 05, 2021	SELL	$67.69 - $73.03 $13,808 - $14,898	-204 Reduced 4.9%	3,958 $276,000
Q2 2021 Aug 11, 2021	BUY	$63.47 - $69.35 $40,176 - $43,898	633 Added 17.94%	4,162 $287,000
Q1 2021 May 03, 2021	SELL	$60.0 - $68.46 $5,520 - $6,298	-92 Reduced 2.54%	3,529 $228,000
Q4 2020 Jan 25, 2021	SELL	$56.65 - $64.55 $113,073 - $128,841	-1,996 Reduced 35.53%	3,621 $211,000
Q3 2020 Oct 30, 2020	BUY	$62.1 - $78.08 $63,466 - $79,797	1,022 Added 22.24%	5,617 $355,000
Q2 2020 Aug 10, 2020	SELL	$72.34 - $84.0 $191,411 - $222,264	-2,646 Reduced 36.54%	4,595 $354,000
Q1 2020 Apr 30, 2020	SELL	$62.63 - $80.22 $89,874 - $115,115	-1,435 Reduced 16.54%	7,241 $541,000
Q4 2019 Feb 03, 2020	BUY	$61.62 - $67.78 $97,852 - $107,634	1,588 Added 22.4%	8,676 $564,000
Q3 2019 Nov 07, 2019	SELL	$62.51 - $69.0 $24,816 - $27,393	-397 Reduced 5.3%	7,088 $449,000
Q2 2019 Jul 09, 2019	SELL	$61.87 - $69.38 $28,769 - $32,261	-465 Reduced 5.85%	7,485 $506,000
Q1 2019 Apr 25, 2019	SELL	$62.53 - $70.05 $25,074 - $28,090	-401 Reduced 4.8%	7,950 $517,000
Q4 2018 Feb 11, 2019	SELL	$60.54 - $79.0 $1,816 - $2,370	-30 Reduced 0.36%	8,351 $522,000
Q3 2018 Oct 24, 2018	SELL	$71.28 - $78.92 $427 - $473	-6 Reduced 0.07%	8,381 $647,000
Q2 2018 Aug 10, 2018	SELL	$64.88 - $75.68 $109,257 - $127,445	-1,684 Reduced 16.72%	8,387 $645,000
Q1 2018 Apr 17, 2018	BUY	$72.84 - $88.8 $22,361 - $27,261	307 Added 3.14%	10,071 $759,000
Q4 2017 Feb 05, 2018	BUY	$71.15 - $83.52 $694,708 - $815,489	9,764	9,764 $790,000

Others Institutions Holding GILD

# of Institutions

1,927

Shares Held

994M

Call Options Held

10.5M

Put Options Held

9.75M

Black Rock Inc. New York, NY

121M
Shares

$11.1 Billion
0.19% of portfolio
Vanguard Group Inc Valley Forge, PA

115M
Shares

$10.7 Billion
0.18% of portfolio
Capital World Investors Los Angeles, CA

76.5M
Shares

$7.07 Billion
1.03% of portfolio
Capital Research Global Investors Los Angeles, CA

61.8M
Shares

$5.71 Billion
1.12% of portfolio
State Street Corp Boston, MA

60.2M
Shares

$5.56 Billion
0.21% of portfolio

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Calton & Associates, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Calton & Associates, Inc. with notifications on news.

Account